Model DetailsLeukocyte - Myelocyte (Granulocyte) leukemia - myelocytic
Model Name |
Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic | Strain |
CD-1 |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
hematopoietic neoplasm • hemato neoplasia, leukemia, granulocytic • hematopoietic tumor • ML, myelocytic leukemia • myeloid leukaemia • granulocytic leukemia, systemic • systemic myeloid leukemia |
Strain Synonyms |
outbred CD-1 • Swiss CD-1® • CD1 nontransgenic • Charles River CD-1 • Swiss CD-1 • Crl:CD-1®(ICR) • outbred CD1 • (Swiss) CD-1 • CD1 • Crl:CD-1(ICR)BR • ICR Crj:CD-1 • random-bred Crl:CD-1(ICR)BR • CD-1 outbred • Crl:CD-1 (ICR) BR • Crj:CD-1(ICR) • ICR(CD-1) • Crl: CD-1 (ICR) BR • ICR |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Leukocyte - Myelocyte (Granulocyte) | Male |
1.4% |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Leukocyte - Myelocyte (Granulocyte) | Male |
4.8% |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Leukocyte - Myelocyte (Granulocyte) | Female |
2.7% |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Leukocyte - Myelocyte (Granulocyte) | Female |
1.5% |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Leukocyte - Myelocyte (Granulocyte) | Male |
1.8% (16 of 891 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte - Myelocyte (Granulocyte) | Female |
1.9% (17 of 890 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte - Myelocyte (Granulocyte) | Male |
1.7% (1 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
| Leukocyte - Myelocyte (Granulocyte) | Female |
0% (0 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
| Leukocyte - Myelocyte (Granulocyte) | Female |
3.2% (1 of 31 mice) |
1 year |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Leukocyte - Myelocyte (Granulocyte) | Female |
4.3% (1 of 23 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Leukocyte - Myelocyte (Granulocyte) | Female |
3.7% (2 of 54 mice) |
1-2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Leukocyte - Myelocyte (Granulocyte) | Male |
0% (0 of 31 mice) |
1 year |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Leukocyte - Myelocyte (Granulocyte) | Male |
0% (0 of 21 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Leukocyte - Myelocyte (Granulocyte) | Male |
0% (0 of 52 mice) |
1-2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Leukocyte - Myelocyte (Granulocyte) | Male |
0% (0 of 1453 mice) |
up to 30 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| Leukocyte - Myelocyte (Granulocyte) | Male |
0.07% (1 of 1453 mice) |
up to 40 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| Leukocyte - Myelocyte (Granulocyte) | Male |
0.14% (2 of 1453 mice) |
up to 50 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| Leukocyte - Myelocyte (Granulocyte) | Female |
0% (0 of 1453 mice) |
up to 30 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| Leukocyte - Myelocyte (Granulocyte) | Female |
0.07% (1 of 1453 mice) |
up to 40 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| Leukocyte - Myelocyte (Granulocyte) | Female |
0.14% (2 of 1453 mice) |
up to 50 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |